# Indolent Non Follicular Lymphomas Prognostic Project

> **NCT02904577** · — · COMPLETED · sponsor: **Fondazione Italiana Linfomi - ETS** · enrollment: 370 (estimated)

## Conditions studied

- Indolent B-Cell Lymphomas

## Interventions

- **OTHER:** Any treatment, watch and wait policy included

## Key facts

- **NCT ID:** NCT02904577
- **Lead sponsor:** Fondazione Italiana Linfomi - ETS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2024-12
- **Final completion:** 2024-12-31
- **Target enrollment:** 370 (ESTIMATED)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02904577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02904577, "Indolent Non Follicular Lymphomas Prognostic Project". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02904577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*